116 related articles for article (PubMed ID: 6120313)
1. Intestinal antibody responses after immunisation with cholera B subunit.
Svennerholm AM; Sack DA; Holmgren J; Bardhan PK
Lancet; 1982 Feb; 1(8267):305-8. PubMed ID: 6120313
[TBL] [Abstract][Full Text] [Related]
2. Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes.
Svennerholm AM; Gothefors L; Sack DA; Bardhan PK; Holmgren J
Bull World Health Organ; 1984; 62(6):909-18. PubMed ID: 6335849
[TBL] [Abstract][Full Text] [Related]
3. Protection against experimental cholera by oral or parenteral immunization.
Peterson JW
Infect Immun; 1979 Nov; 26(2):594-8. PubMed ID: 546789
[TBL] [Abstract][Full Text] [Related]
4. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
[TBL] [Abstract][Full Text] [Related]
5. Current status of an oral B subunit whole cell cholera vaccine.
Svennerholm AM; Jertborn M; Gothefors L; Karim A; Sack DA; Holmgren J
Dev Biol Stand; 1983; 53():73-9. PubMed ID: 6873479
[TBL] [Abstract][Full Text] [Related]
6. Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge.
Lycke N; Bromander AK; Holmgren J
Int Arch Allergy Appl Immunol; 1989; 88(3):273-9. PubMed ID: 2785966
[TBL] [Abstract][Full Text] [Related]
7. Maternal cholera immunisation and scecretory IgA in breast milk.
Merson MH; Black RE; Sack DA; Svennerholm AM; Holmgren J
Lancet; 1980 Apr; 1(8174):931-2. PubMed ID: 6103281
[No Abstract] [Full Text] [Related]
8. IgG and IgA subclass distribution of antitoxin antibody responses after oral cholera vaccination or cholera disease.
Jertborn M; Svennerholm AM; Holmgren J
Int Arch Allergy Appl Immunol; 1988; 85(3):358-63. PubMed ID: 3350611
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with a free peptide from cholera toxin: local protection and IgA production.
Pedoussaut S; Delmas A; Milhaud G; Rivaille P; Gruaz-Guyon A
Mol Immunol; 1989 Feb; 26(2):115-9. PubMed ID: 2918857
[TBL] [Abstract][Full Text] [Related]
10. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
Stewart-Tull DE; Lucas C; Bleakley CR
Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
[TBL] [Abstract][Full Text] [Related]
11. Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation.
Karlsen TH; Sommerfelt H; Klomstad S; Andersen PK; Strand TA; Ulvik RJ; Ahrén C; Grewal HM
Infect Immun; 2003 Jul; 71(7):3909-13. PubMed ID: 12819076
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.
Migasena S; Pitisuttitham P; Suntharasamai P; Prayurahong B; Supanaranond W; Desakorn V; Black RE
Infect Immun; 1989 Jul; 57(7):1942-5. PubMed ID: 2731977
[TBL] [Abstract][Full Text] [Related]
13. Amplification of the secretory IgA response to Toxoplasma gondii using cholera toxin.
Bourguin I; Chardes T; Mevelec MN; Woodman JP; Bout D
FEMS Microbiol Lett; 1991 Jul; 65(3):265-71. PubMed ID: 1916225
[TBL] [Abstract][Full Text] [Related]
14. Immune function in transplanted small intestine. Total secretory IgA production and response against cholera toxin.
Xia WY; Kirkman RL
Transplantation; 1990 Feb; 49(2):277-80. PubMed ID: 2305456
[TBL] [Abstract][Full Text] [Related]
15. Immune response following oral administration of cholera toxin B subunit to HIV-1-infected UK and Kenyan subjects.
Lewis DJ; Gilks CF; Ojoo S; Castello-Branco LR; Dougan G; Evans MR; McDermott S; Griffin GE
AIDS; 1994 Jun; 8(6):779-85. PubMed ID: 8086136
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
17. The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.
Kay RA; Ferguson A
Immunology; 1989 Mar; 66(3):410-5. PubMed ID: 2703255
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans.
Wassen L; Jertborn M
Clin Diagn Lab Immunol; 2005 Mar; 12(3):447-52. PubMed ID: 15753258
[TBL] [Abstract][Full Text] [Related]
19. Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice.
Svennerholm A; Lange S; Holmgren J
Infect Immun; 1978 Jul; 21(1):1-6. PubMed ID: 711308
[TBL] [Abstract][Full Text] [Related]
20. The origins of secretory IgA in milk: a shift during lactation from a serum origin to local synthesis in the mammary gland.
Halsey JF; Mitchell CS; McKenzie SJ
Ann N Y Acad Sci; 1983 Jun; 409():452-60. PubMed ID: 6575713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
